Mohan Hosahalli K, Livieratos Lefteris, Peters A Michael
Department of Nuclear Medicine, Guys & St Thomas' Hospitals NHS Trust, London, UK.
Department of Nuclear Medicine, King's College Hospital NHS Foundation Trust, London, UK.
Clin Physiol Funct Imaging. 2019 Jul;39(4):236-239. doi: 10.1111/cpf.12562. Epub 2019 Feb 7.
Tc-99m-methoxyisobutyl isonitrile (Tc-99m-MIBI) is a radiolabelled xenobiotic, the disappearance rate of which from lungs following inhalation as a radioaerosol correlates inversely with bronchopulmonary multidrug resistance protein 1 (MRP1) expression. Tc-99m-MIBI clearance has previously been shown to be delayed in cigarette smokers. The aim of the current study was to determine whether smoking correlates with bronchopulmonary MRP1 expression, to confirm that Tc-99m-MIBI disappearance rate from the lungs following inhalation is delayed in smokers, and to determine the effects of gender and age on disappearance rate. Participants underwent dynamic imaging for 40 min over the lungs following inhalation of Tc-99m-MIBI using a double-headed gamma camera. The half-time of clearance was obtained from geometric mean of anterior and posterior counts and averaged between the two lungs. Paraffin-embedded tissue obtained from healthy lung during surgery in 13 patients was graded immunohistochemically for MRP1 as negative (0), weak (1), moderate (2) or strong (3). In 4 non-smokers, grading was 1 in three and 0 in one. In 9 smokers, in contrast, expression was graded 2-3 in 8 and 1 in one (P<0·02). Mean clearance half-time in smokers (142 ± 29 min; n = 17) was longer than in non-smokers (91 ± 14 min; n = 18; P<0·0001). In non-smokers, half-times were not significantly different between men (96 ± 16; n = 6) min and women (88 ± 12 min; P = 0·2). Combining genders into one group, half-time correlated with participant age (P = 0·0005). We conclude that smoking upregulates MRP1 and delays clearance of inhaled Tc-99m-MIBI. There is no significant gender difference in non-smokers but ageing is associated with longer clearance half-times.
锝-99m-甲氧基异丁基异腈(Tc-99m-MIBI)是一种放射性标记的外源性物质,其作为放射性气溶胶吸入后从肺部的消失速率与支气管肺多药耐药蛋白1(MRP1)的表达呈负相关。先前已表明,吸烟者体内Tc-99m-MIBI的清除会延迟。本研究的目的是确定吸烟是否与支气管肺MRP1表达相关,确认吸烟者吸入后Tc-99m-MIBI从肺部的消失速率是否延迟,并确定性别和年龄对消失速率的影响。参与者在吸入Tc-99m-MIBI后,使用双头伽马相机对肺部进行了40分钟的动态成像。清除半衰期从前后计数的几何平均值中获得,并在两肺之间进行平均。对13例患者手术中获取的健康肺石蜡包埋组织进行免疫组织化学分级,MRP1分级为阴性(0)、弱阳性(1)、中度阳性(2)或强阳性(3)。在4名不吸烟者中,3人分级为1,1人分级为0。相比之下,在9名吸烟者中,8人表达分级为2 - 3,1人分级为1(P<0·02)。吸烟者的平均清除半衰期(142±29分钟;n = 17)长于不吸烟者(91±14分钟;n = 18;P<0·0001)。在不吸烟者中,男性(96±16;n = 6)和女性(88±12分钟;P = 0·2)的半衰期无显著差异。将男女合并为一组后,半衰期与参与者年龄相关(P = 0·0005)。我们得出结论,吸烟会上调MRP1并延迟吸入的Tc-99m-MIBI的清除。不吸烟者中无显著性别差异,但年龄增长与清除半衰期延长有关。